Lin stated, "we remain on track to complete the [DRAGON] study in Q4 this year." Lin shared, "the FDA recommended that we complete the 24-month study, which we are about to complete coming up in ...

These amounts were included in SG&A and represent severance and restructuring costs related to the Company's 2024 corporate initiatives and the associated organizational redesign efforts. Non-GAAP ...

Use of Non-GAAP Financial Measures: This press release contains financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S. (GAAP). We ...

Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round attracted prominent leaders in AI and ...

Orientation at Boston College — a time when incoming students register for classes, meet peers and learn about campus resources — lasts three days. The school year at this Jesuit Catholic university ...

I rate Bio-Rad (BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect. For 2025, the company expects a 0.25% growth rate for its revenues, which might ...

The FBS regular season is in the books and 29 first-year coaches have finished their debut seasons. Here’s a recap of how they did, ranking their performances from top to bottom. Jerry Mack won the ...